Benjamin Ory

12PUBLICATIONS
63CO-AUTHORS
Molecular targetsGenome structure and regulationPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 13, 2024
Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium Statement.

Darrell Green, Roelof van Ewijk, Elisa Tirtei

|Apr 08, 2024
Super-enhancers: drivers of cells' identities and cells' debacles.

Mélanie Lavaud, Robel Tesfaye, Léa Lassous

|Jun 12, 2023
Tracking Targets of Dynamic Super-Enhancers in Vitro to Better Characterize Osteoclastogenesis and to Evaluate the Effect of Diuron on the Maturation of Human Bone Cells.

Robel A Tesfaye, Melanie Lavaud, Céline Charrier

|Dec 11, 2022
The p53 Family Members p63 and p73 Roles in the Metastatic Dissemination: Interactions with microRNAs and TGFβ Pathway.

Lidia Rodriguez Calleja, Melanie Lavaud, Robel Tesfaye

|Jul 27, 2022
Origin and Therapies of Osteosarcoma.

Brice Moukengue, Morgane Lallier, Louise Marchandet

|Sep 28, 2021
Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619.

Mélanie Lavaud, Mathilde Mullard, Robel Tesfaye

Pageof 2

Frequent Collaborators

5 joint publications

Franck Verrecchia

3 joint publications

Bénédicte Brounais-Le-Royer

2 joint publications

Frédéric Lézot

2 joint publications

Robel Tesfaye